Your browser is no longer supported. Please, upgrade your browser.
Settings
BDX Becton, Dickinson and Company daily Stock Chart
BDX [NYSE]
Becton, Dickinson and Company
IndexS&P 500 P/E46.93 EPS (ttm)4.65 Insider Own0.20% Shs Outstand229.14M Perf Week-0.28%
Market Cap50.02B Forward P/E18.83 EPS next Y11.59 Insider Trans-14.77% Shs Float227.34M Perf Month-2.75%
Income1.03B PEG4.17 EPS next Q2.45 Inst Own91.00% Short Float5.51% Perf Quarter7.97%
Sales12.09B P/S4.14 EPS this Y2.70% Inst Trans0.89% Short Ratio10.20 Perf Half Y13.49%
Book/sh56.71 P/B3.85 EPS next Y9.94% ROA3.30% Target Price240.31 Perf Year31.11%
Cash/sh61.97 P/C3.52 EPS next 5Y11.27% ROE10.00% 52W Range161.50 - 229.68 Perf YTD31.87%
Dividend3.00 P/FCF43.65 EPS past 5Y-2.80% ROI4.80% 52W High-4.45% Beta1.09
Dividend %1.37% Quick Ratio5.00 Sales past 5Y9.40% Gross Margin49.10% 52W Low35.89% ATR3.96
Employees41900 Current Ratio5.60 Sales Q/Q-2.00% Oper. Margin11.60% RSI (14)50.55 Volatility1.22% 1.52%
OptionableYes Debt/Eq1.46 EPS Q/Q1716.70% Profit Margin8.50% Rel Volume1.10 Prev Close218.31
ShortableYes LT Debt/Eq1.44 EarningsNov 02 BMO Payout61.30% Avg Volume1.23M Price219.47
Recom1.90 SMA20-1.29% SMA502.69% SMA20011.37% Volume300,041 Change0.53%
Nov-03-17Reiterated RBC Capital Mkts Sector Perform $210 → $230
Sep-22-17Initiated Wells Fargo Outperform $225
Jun-30-17Upgrade Raymond James Outperform → Strong Buy
Jan-05-17Downgrade Raymond James Strong Buy → Outperform
Jan-03-17Downgrade JP Morgan Overweight → Neutral
Sep-23-16Downgrade Citigroup Neutral → Sell
May-09-16Reiterated RBC Capital Mkts Sector Perform $153 → $169
Feb-11-16Upgrade Deutsche Bank Hold → Buy $155 → $163
Feb-04-16Reiterated RBC Capital Mkts Sector Perform $162 → $153
Jan-04-16Downgrade Morgan Stanley Overweight → Equal-Weight
Nov-12-15Initiated Citigroup Neutral
Aug-19-15Reiterated Argus Buy $156 → $167
Aug-10-15Reiterated Deutsche Bank Hold $147 → $155
Aug-07-15Reiterated RBC Capital Mkts Sector Perform $150 → $162
Jul-02-15Resumed Barclays Equal Weight $158
Jun-29-15Upgrade UBS Neutral → Buy $159 → $167
Mar-24-15Reiterated Canaccord Genuity Hold $125 → $149
Mar-10-15Initiated UBS Neutral $159
Feb-11-15Reiterated Argus Buy $140 → $156
Feb-06-15Reiterated RBC Capital Mkts Outperform $145 → $150
Dec-11-17 03:40PM  10 Super Safe Growth Stocks to Buy for Long-Lasting Dividends InvestorPlace
06:59AM  BD Establishes Product Security Partnership Program to Enhance Cybersecurity of Medical Technology PR Newswire
Dec-08-17 11:16AM  Becton, Dickinson & Co. : BDX-US: Dividend Analysis : December 08th, 2017 (record date) : By the numbers : December 8, 2017 Capital Cube
08:01AM  See what the IHS Markit Score report has to say about Becton Dickinson and Co. Markit
Dec-07-17 01:01PM  ETFs with exposure to Becton, Dickinson & Co. : December 7, 2017 Capital Cube
Dec-06-17 08:11AM  Becton, Dickinson Focuses on Medication Management, Stock Up Zacks
08:01AM  See what the IHS Markit Score report has to say about Becton Dickinson and Co. Markit
Dec-05-17 08:52AM  Becton, Dickinson & Co. :BDX-US: Earnings Analysis: Q4, 2017 By the Numbers : December 5, 2017 Capital Cube
08:01AM  See what the IHS Markit Score report has to say about Becton Dickinson and Co. Markit
Dec-04-17 08:01AM  See what the IHS Markit Score report has to say about Becton Dickinson and Co. Markit
06:59AM  BD Announces New Offerings to Help Customers Deliver Safer, Simpler and Smarter Medication Management PR Newswire
Dec-01-17 09:02AM  Why Most Analysts Recommend Buy for BD Market Realist
07:32AM  BDs Recent Dividend Increase: What Investors Need to Know Market Realist
Nov-30-17 07:35AM  How Emerging Markets Continue to be the Key Growth Driver for BD Market Realist
Nov-29-17 10:55AM  The Impact of Dispensing Business Changes on BDs Revenue Market Realist
09:23AM  BD Stock Reaches 52-Week High on November 27 Market Realist
08:30AM  Market Trends Toward New Normal in U.S., Becton, Dickinson, Cigna, Aetna, Enphase Energy, and Vishay Intertechnology Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Nov-28-17 06:30AM  BD Announces Extension of Exchange Offers and Consent Solicitations for C. R. Bard, Inc. Notes PR Newswire
Nov-27-17 12:16PM  ETFs with exposure to Becton, Dickinson & Co. : November 27, 2017 Capital Cube
06:04AM  3 Top Diabetes Stocks to Buy Now Motley Fool
Nov-26-17 11:08AM  These 3 Stocks Just Raised Their Dividends Motley Fool
Nov-23-17 10:13AM  Becton, Dickinson & Co. :BDX-US: Earnings Analysis: 2017 By the Numbers : November 23, 2017 Capital Cube
Nov-22-17 12:48PM  Becton, Dickinson and Co (BDX) Files 10-K for the Fiscal Year Ended on September 30, 2017 GuruFocus.com
Nov-20-17 04:30PM  BD Board Increases Dividend PR Newswire
07:20AM  Featured Company News - Merit Medical Signs Agreement with Becton, Dickinson & Co. to Acquire Divestment Assets ACCESSWIRE
Nov-17-17 08:56AM  The Zacks Analyst Blog Highlights: Baxter International, BostonScientific, Intuitive Surgical and Becton and Dickinson Zacks
Nov-16-17 12:30PM  Trump Focuses on APAC: 4 MedTech Stocks to Watch Zacks
09:40AM  See what the IHS Markit Score report has to say about Becton Dickinson and Co. Markit
08:00AM  BD to Introduce Integrated Medication Management Platform Designed to Address Hospitals' Greatest Challenges at #ASHP17 PR Newswire
06:36AM  BD Statement On Merit Medical Agreement To Purchase BD, Bard Product Lines PR Newswire
Nov-15-17 08:01AM  See what the IHS Markit Score report has to say about Becton Dickinson and Co. Markit
Nov-14-17 08:01AM  See what the IHS Markit Score report has to say about Becton Dickinson and Co. Markit
Nov-13-17 08:03PM  Delivering medical supplies into the remote Amazon is a big challenge, but drones could help CNBC
07:01PM  These drones can save lives with quick medical deliveries CNBC Videos
Nov-08-17 02:40PM  Becton, Dickinson and Co Shows It's "Consistent" and "Reliable" in the Face of Headwinds Motley Fool
Nov-06-17 07:32AM  Becton Dickinson and Company Rose on November 2 Market Realist
Nov-03-17 11:35AM  Edited Transcript of BDX earnings conference call or presentation 2-Nov-17 12:00pm GMT Thomson Reuters StreetEvents
08:35AM  Becton Dickinson (BDX) in Focus: Stock Moves 7.7% Higher Zacks
03:00AM  Becton Dickinson Reaches 80-Plus Relative Strength Rating Benchmark Investor's Business Daily
Nov-02-17 10:42AM  What Should We Expect From Becton Dickinson and Companys (BDX) Earnings In The Year Ahead? Simply Wall St. +7.67%
10:14AM  Becton, Dickinson (BDX) Beats on Q4 Earnings, Guidance Solid Zacks
07:54AM  Becton (BDX) Tops Q4 Earnings and Revenues Estimates Zacks
06:20AM  Becton Dickinson beats Street 4Q forecasts Associated Press
06:00AM  BD Announces Results For 2017 Fourth Fiscal Quarter And Full Year; Provides Fiscal 2018 Guidance PR Newswire
Nov-01-17 12:30PM  Key MedTech Trends to Influence Q3 Earnings: BDX, ABC, TFX Zacks
Oct-31-17 08:30AM  Is Becton, Dickinson (BDX) Poised for a Beat in Q4 Earnings? Zacks
Oct-26-17 08:01AM  See what the IHS Markit Score report has to say about Becton Dickinson and Co. Markit
06:30AM  BD Announces Extension of Exchange Offers and Consent Solicitations for C. R. Bard, Inc. Notes PR Newswire
Oct-25-17 02:04PM  BD Breaks Ground on $60 Million Expansion of Nebraska Manufacturing Facility PR Newswire
Oct-24-17 08:01AM  See what the IHS Markit Score report has to say about Becton Dickinson and Co. Markit
Oct-19-17 08:01AM  See what the IHS Markit Score report has to say about Becton Dickinson and Co. Markit
Oct-18-17 10:17AM  BD Statement On European Commission Conditional Clearance Of Bard Acquisition PR Newswire
10:10AM  Becton Dickinson wins conditional EU approval for $24 bln Bard buy Reuters
Oct-16-17 11:06AM  EU mergers and takeovers (Oct 16) Reuters
Oct-09-17 08:15AM  Becton, Dickinson & Co. breached its 50 day moving average in a Bullish Manner : BDX-US : October 9, 2017 Capital Cube
08:01AM  See what the IHS Markit Score report has to say about Becton Dickinson and Co. Markit
Oct-06-17 11:43AM  Behind BDs Latest Analyst Recommendations Market Realist
Oct-05-17 04:30PM  BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call PR Newswire
Oct-03-17 10:55AM  ETFs with exposure to Becton, Dickinson & Co. : October 3, 2017 Capital Cube
Oct-02-17 03:58PM  Becton, Dickinson's Charts Are Bullish TheStreet.com
Sep-29-17 10:42AM  Timothy M. Ring and David F. Melcher to Join BD Board of Directors PR Newswire
Sep-28-17 06:09AM  Becton Dickinson offers EU concessions over $24 bln Bard deal Reuters
Sep-27-17 09:55AM  Becton, Dickinson & Co. : BDX-US: Dividend Analysis : September 08th, 2017 (record date) : By the numbers : September 27, 2017 Capital Cube
08:00AM  See what the IHS Markit Score report has to say about Becton Dickinson and Co. Markit
06:30AM  BD Announces Extension of Exchange Offers and Consent Solicitations for C. R. Bard, Inc. Notes PR Newswire
Sep-26-17 08:01AM  See what the IHS Markit Score report has to say about Becton Dickinson and Co. Markit
04:00AM  BD Expands Efforts to Combat Antimicrobial Resistance with New Diagnostic Test in Europe PR Newswire
Sep-25-17 08:00AM  See what the IHS Markit Score report has to say about Becton Dickinson and Co. Markit
Sep-22-17 11:03AM  ETFs with exposure to Becton, Dickinson & Co. : September 22, 2017 Capital Cube
08:00AM  See what the IHS Markit Score report has to say about Becton Dickinson and Co. Markit
Sep-21-17 12:09PM  Becton, Dickinson & Co. :BDX-US: Earnings Analysis: Q3, 2017 By the Numbers : September 21, 2017 Capital Cube
08:42AM  BD (BDX) Inks New Deal to Strengthen Foothold in STI Space Zacks
08:00AM  See what the IHS Markit Score report has to say about Becton Dickinson and Co. Markit
Sep-20-17 10:16AM  Becton, Dickinson Ultra-Fine Needle to Improve Diabetic Care Zacks
08:00AM  See what the IHS Markit Score report has to say about Becton Dickinson and Co. Markit
04:00AM  BD and Euroclone Announce Development and Global Distribution Agreement for Tests to Detect Emerging Sexually-Transmitted Pathogens PR Newswire
Sep-19-17 06:59AM  BD Introduces New 6mm Pen Needle for Injection Pens PR Newswire
Sep-15-17 02:06PM  Whats BDs Recent Dividend Payment and Capital Allocation Strategy? Market Realist
12:35PM  BD Stock Fell 2.7% on September 13: Should Investors Worry? Market Realist
Sep-14-17 10:24AM  Becton, Dickinson & Co. breached its 50 day moving average in a Bearish Manner : BDX-US : September 14, 2017 Capital Cube
Sep-12-17 09:42AM  Becton, Dickinson's (BCR) C.R. Bard Buyout Plans Bode Well Zacks
08:00AM  See what the IHS Markit Score report has to say about Becton Dickinson and Co. Markit
06:59AM  BD Expands Genomics Portfolio with New Single Cell Platform for RNA Expression Analysis PR Newswire
Sep-11-17 10:06AM  The Zacks Analyst Blog Highlights: Home Depot, Aetna, Dickinson, Kellogg and FirstEnergy Zacks
10:05AM  See what the IHS Markit Score report has to say about Becton Dickinson and Co. Markit
Sep-08-17 05:18PM  Top Analyst Reports for Home Depot, Aetna & Becton, Dickinson Zacks
04:18PM  BD to Present at the Morgan Stanley Global Healthcare Conference 2017 PR Newswire
10:21AM  See what the IHS Markit Score report has to say about Becton Dickinson and Co. Markit
Sep-06-17 07:40AM  Dividend Coverage: This Medical Tech Company has Raised Dividend for 45 Consecutive Years; Will Trade Ex-Dividend on September 07, 2017 ACCESSWIRE
03:00AM  Becton Dickinson Trying To Close In On Key Technical Benchmark Investor's Business Daily
Sep-01-17 08:01AM  See what the IHS Markit Score report has to say about Becton Dickinson and Co. Markit
Aug-31-17 09:55AM  Becton, Dickinson & Co. breached its 50 day moving average in a Bearish Manner : BDX-US : August 31, 2017 Capital Cube
Aug-30-17 10:35AM  Becton Dickinsons Recent Stock Performance Market Realist
09:06AM  Most Analysts Recommend a Buy for Becton Dickinson Market Realist
07:36AM  Becton Dickinson Raised Its 2017 Guidance, Expects Better Margins Market Realist
Aug-29-17 10:38AM  How Innovation Is Driving Becton Dickinsons Growth in 2017 Market Realist
09:07AM  Becton Dickinsons CareFusion Synergies and Integration Progress Market Realist
07:38AM  How Is Becton Dickinson Progressing with Emerging Market Growth? Market Realist
06:30AM  BD Announces Extension of Exchange Offers and Consent Solicitations for C. R. Bard, Inc. Notes PR Newswire
Aug-28-17 11:36AM  Becton Dickinsons Bard Acquisition: On Track, Gaining Momentum Market Realist
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. It operates in two segments, BD Medical and BD Life Sciences. The BD Medical segment offers syringes, pen needles, and IV sets for diabetes; needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; regional anesthesia needles and trays; sharps disposal containers; closed-system transfer devices; skin antiseptic products; surgical and laproscopic instrumentations; intravenous medication safety and infusion therapy delivery, and automated medication dispensing and supply management systems; and prefillable drug delivery systems. The BD Life Sciences segment provides integrated systems for specimen collection; safety-engineered blood collection, automated blood culturing and tuberculosis culturing, and microorganism identification and drug susceptibility systems; molecular testing systems for infectious diseases and women's health; liquid-based cytology systems for cervical cancer screening; rapid diagnostic assays; microbiology laboratory automation, and plated media products; fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; molecular indexing and next-generation sequencing sample preparation for genomics research; clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers; and cell culture media supplements for biopharmaceutical manufacturing. The company markets its products through independent distribution channels and sales representatives to healthcare institutions, life science researchers, clinical laboratories, pharmaceutical industry, and general public. It has a strategic collaboration with FlowJo, LLC. Becton, Dickinson and Company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
COHEN GARY MExecutive Vice PresidentSep 11Option Exercise72.1224,0111,731,67395,781Sep 11 02:48 PM
COHEN GARY MExecutive Vice PresidentSep 11Sale203.7715,5123,160,88071,770Sep 11 02:48 PM
Sichak StephenExecutive Vice PresidentSep 08Option Exercise113.0427,0333,055,69219,047Sep 11 09:17 AM
Sichak StephenExecutive Vice PresidentSep 08Sale200.4611,7872,362,8227,953Sep 11 09:17 AM
Lim James CExecutive Vice PresidentSep 08Sale204.063,500714,21014,135Sep 11 09:10 AM
COHEN GARY MExecutive Vice PresidentAug 22Option Exercise72.1223,5001,694,82095,270Aug 23 05:11 PM
Tharby Linda MExecutive Vice PresidentAug 22Option Exercise72.127,333528,85618,670Aug 23 05:45 PM
Tharby Linda MExecutive Vice PresidentAug 22Sale200.484,695941,25411,337Aug 23 05:45 PM
COHEN GARY MExecutive Vice PresidentAug 22Sale200.4315,0443,015,26971,770Aug 23 05:11 PM
Shabshab NabilExecutive Vice PresidentAug 15Sale202.372,865579,7905,839Aug 16 10:12 AM
Shabshab NabilExecutive Vice PresidentAug 14Option Exercise140.2610,8431,520,88315,648Aug 16 10:12 AM
Mas Ribo AlbertoEVP and Pres, Life SciencesAug 14Option Exercise76.1812,003914,38929,323Aug 14 04:52 PM
Shabshab NabilExecutive Vice PresidentAug 14Sale201.223,284660,8068,704Aug 16 10:12 AM
Mas Ribo AlbertoEVP and Pres, Life SciencesAug 14Sale201.417,4631,503,12317,320Aug 14 04:52 PM
Strahlman Ellen RSenior Vice PresidentAug 10Option Exercise108.8920,6012,243,24326,638Aug 11 09:57 AM
Strahlman Ellen RSenior Vice PresidentAug 10Sale198.219,2831,839,9836,037Aug 11 09:57 AM
Polen Thomas E JrExecutive Vice PresidentAug 09Option Exercise98.9111,9711,184,06517,528Aug 10 10:08 AM
Polen Thomas E JrExecutive Vice PresidentAug 09Sale197.415,9711,178,7359,209Aug 10 10:08 AM
SHERMAN JEFFREY SSr. VP and General CounselMay 25Option Exercise76.1848,7273,712,02370,821May 26 10:25 AM
SHERMAN JEFFREY SSr. VP and General CounselMay 25Sale185.9828,7655,349,71522,094May 26 10:25 AM
SHERMAN JEFFREY SSr. VP and General CounselFeb 15Option Exercise72.1244,3643,199,53266,458Feb 16 08:57 AM
SHERMAN JEFFREY SSr. VP and General CounselFeb 15Sale180.0231,4645,664,24622,094Feb 16 08:57 AM
Conroy AlexandreExecutive Vice PresidentFeb 14Sale177.868,5001,511,81023,676Feb 15 11:31 AM
Gallagher John EVP, Corp Finance and TreasurerDec 15Sale168.821,793302,6942,796Dec 16 01:50 PM